Company / EPS (Diluted)
ORTHOPEDIATRICS CORP EPS (Diluted) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.92
FY2025
5-year range
-$1.82 / $0.06
FY2021-FY2025
Trend
-1633.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -1633% YoY in FY2025, a notable deviation from the 8-year average annual change of -183%.
Based on SEC 10-K filings.
-0.92 in FY2025.
Declined from $-0.84 to $-0.92 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 1633.3% year-over-year.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.92 | -1633.3% |
| FY2024 | $0.06 | +107.1% |
| FY2023 | -$0.84 | +53.8% |
| FY2022 | -$1.82 | -93.6% |
| FY2021 | -$0.94 | +2.1% |
| FY2020 | -$0.96 | +83.6% |
| FY2019 | -$5.86 | +17.9% |
| FY2018 | -$7.14 | +1.8% |
| FY2017 | -$7.27 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026